XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price. One Chinese company (DHRM) is on the list. Alpha Pro Tech, Ltd. (AMEX:APT) has the 1st highest upside potential in this segment of the market. Its upside is 667.5%. Its consensus target price is $8.75 based on the average of all estimates. Dehaier Medical Systems Ltd (NASDAQ:DHRM) has the 2nd highest upside potential in this segment of the market. Its upside is 432.5%. Its consensus target price is $9.00 based on the average of all estimates. Vermillion, Inc. (NASDAQ:VRML) has the 3rd highest upside potential in this segment of the market. Its upside is 325.5%. Its consensus target price is $6.00 based on the average of all estimates. Delcath Systems, Inc. (NASDAQ:DCTH) has the 4th highest upside potential in this segment of the market. Its upside is 279.7%. Its consensus target price is $9.00 based on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 5th highest upside potential in this segment of the market. Its upside is 257.1%. Its consensus target price is $1.00 based on the average of all estimates. Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) has the 6th highest upside potential in this segment of the market. Its upside is 243.1%. Its consensus target price is $8.75 based on the average of all estimates. IsoRay, Inc. (AMEX:ISR) has the 7th highest upside potential in this segment of the market. Its upside is 237.1%. Its consensus target price is $3.00 based on the average of all estimates. Stereotaxis, Inc. (NASDAQ:STXS) has the 8th highest upside potential in this segment of the market. Its upside is 231.6%. Its consensus target price is $3.15 based on the average of all estimates. TranS1 Inc. (NASDAQ:TSON) has the 9th highest upside potential in this segment of the market. Its upside is 211.4%. Its consensus target price is $4.86 based on the average of all estimates. iCAD, INC. (NASDAQ:ICAD) has the 10th highest upside potential in this segment of the market. Its upside is 203.0%. Its consensus target price is $2.00 based on the average of all estimates.
No comments:
Post a Comment